FOXM1 and breast cancer: Clinical doses of ionizing radiation are known to stimulate the invasive properties of ErbB2-positive breast cancer cells and, moreover, radiation resulted in activation of ErbB2, which, through activation of FoxM1, promoted invasion of breast cancer cells [49].